Page 28 - Pharmaceutical Firms
Zydus Cadila Q2 net up four-fold on surge in US sales, strong show at home
Firm prunes net debt by 40% since March 2020; consolidated income up 13%
 "Zydus Cadila Q2 net up four-fold on surge in US sales, strong show at home")
With 350% stock gain, drugmaker Laurus Labs seeks to boost capacity
The pharmaceutical sector is the top performer in India's $2.1 trillion equity market this year after the coronavirus pandemic turned global investors' spotlight on health-care companies
 "With 350% stock gain, drugmaker Laurus Labs seeks to boost capacity")
Glenmark Pharma launches pulmonary fibrosis treatment drug in India
Glenmark Pharma announced the launch of its generic version of Nintedanib (NINDANIB), used for the treatment of pulmonary fibrosis, in India
 "Glenmark Pharma launches pulmonary fibrosis treatment drug in India")
Pharma, FMCG push hiring activity in India by 24% in September: Naukri.com
Driven by industries like pharma, fast-moving consumer goods, education and IT, hiring activity in India saw a growth of 24% in September compared to the previous month
 "Pharma, FMCG push hiring activity in India by 24% in September: Naukri.com")
Madras HC orders formation of panel to ensure self-reliance in cancer drugs
In its judgment the court said India can not be dependent on China for APIs and ordered the formation of a five member committee to ensure self-reliance
 "Madras HC orders formation of panel to ensure self-reliance in cancer drugs")
Bank fraud case: 4 Sterling directors declared fugitive economic offenders
A Delhi court on Monday declared four directors of a Gujarat-based pharma firm,Sterling Biotech Ltd (SBL), fugitive economic offenders in a Rs 8,100-crore bank fraud case
 "Bank fraud case: 4 Sterling directors declared fugitive economic offenders")
Hetero launches pack of generic Covid-19 drug favipiravir at Rs 2,640
Drug firm Hetero on Friday said it has launched a pack of its generic oral antiviral drug-- Favivir 800/200-- for the treatment of mild-to-moderate symptomatic COVID-19 patients in India.
 "Hetero launches pack of generic Covid-19 drug favipiravir at Rs 2,640")
Higher exports to help pharma eke out 8-9% growth this fiscal: CRISIL
Living up to its moniker of a defensive bet, the Rs 2.8 trn Indian pharmaceutical sector is set to emerge more or less unscathed from the Covid-19 pandemic this fiscal, CRISIL said on Thursday.
 "Higher exports to help pharma eke out 8-9% growth this fiscal: CRISIL")
India probing alleged dumping of chemical from China, South Korea
In the probe, the directorate will determine the existence, degree and effect of any alleged dumping in respect of the product from China
 "India probing alleged dumping of chemical from China, South Korea")
Pharma companies committed to science-first policy on Covid-19 vaccine
Pharmaceutical companies are committed to a science first approach in the development of COVID-19 vaccines even as the pressure piles on to end the pandemic
 "Pharma companies committed to science-first policy on Covid-19 vaccine")
Zydus Cadila gets USFDA nod to market mineral supplement tablets
Zydus Cadila said it has received approval from USFDA to market potassium chloride extended release tablets, a mineral supplement used to treat or prevent low amounts of potassium in the blood
Dr Reddy's, Biocon, Torrent Pharma: What charts indicate for these stocks
The next upside for Nifty Pharma is located above the resistance of 12,100 levels.
Gilead to buy cancer drugmaker Immunomedics Inc for $21 billion
Gilead Sciences Inc will acquire biopharmaceutical company Immunomedics Inc for $21 billion, a move that will strengthen its cancer portfolio by gaining access to a promising drug
 "Gilead to buy cancer drugmaker Immunomedics Inc for $21 billion")
Vaccine majors see sharp rally with some players rising more than 4,000%
The Indian pharmaceutical sector has also been going through a surge
 "Vaccine majors see sharp rally with some players rising more than 4,000%")
India scaling up production of active pharmaceutical ingredients: Kant
India, a global hub for generic drugs, has launched a new scheme to boost production of active pharmaceutical ingredients that are greatly dependent on the Chinese supply chain, according to Kant
Pharma sector needs global collaboration: Industry leaders, govt officials
The need of global collaboration in the pharma sector from research and development to drug manufacturing has never been as great as it is now amid the deadly COVID pandemic
Covid-19 prescription: Pharma players shift their focus over the counter
The pandemic pushes pharma companies to look at drugs that held promise in transitioning to over the counter segment
Domestic pharma firms working on new repurposed drug for Covid-19
Advantage over conventional plasma therapy is it will have standard antibodies
 "Domestic pharma firms working on new repurposed drug for Covid-19")
R&D for treating Covid-19 by pharmaceutical firms part of CSR activities
Activities undertaken by companies in normal course of business also part of CSR
Pharma to lose pandemic-induced pricing power in Q2 as economies reopen
Pharma companies are unlikely to sustain the healthy operating performance reported in the first quarter as they will lose the margins booked during the global lockdowns